Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia
- PMID: 29490691
- PMCID: PMC5831205
- DOI: 10.1186/s13195-018-0356-0
Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia
Abstract
Background: Dementia due to Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are the two most common neurodegenerative causes of dementia. They commonly occur together, especially in older people, but clinical identification of these diseases in dementia is difficult in such circumstances. We therefore conducted a study using cases with both comprehensive prospective clinical assessments and complete neuropathological examination to determine if it is possible to identify such mixed cases clinically and to determine features which may identify DLB in the presence of AD dementia.
Methods: At Newcastle Brain Bank we identified subjects who had a clinical diagnosis of dementia and who also had autopsy diagnoses of pure AD, pure DLB, or mixed AD+DLB. All subjects had undergone prospective longitudinal clinical assessments. Mixed AD+DLB patients met neuropathological criteria for both DLB (limbic/neocortical Lewy body disease) and AD (Braak stage V/VI and CERAD B/C). The records of these subjects were carefully reviewed by two specialists in old-age psychiatry blind to autopsy findings to determine baseline and final clinical diagnoses based on these detailed records. The presence of characteristic Lewy body symptoms and other clinical information was also recorded.
Results: Of 59 subjects included, 19 were AD, 18 DLB, and 22 mixed AD+DLB. At baseline no subjects were correctly identified as having mixed AD+DLB and by final diagnosis only 23% were identified. The only symptom which helped in identifying the presence of Lewy body disease in the context of a mixed AD+DLB dementia was complex visual hallucinations.
Conclusions: Whilst the identification of DLB in the context of a dementia with an AD pattern is difficult, the emergence of complex visual hallucinations in the context of such a degenerative dementia suggests the presence of Lewy body disease and should encourage a careful assessment. Biomarkers appear likely to be necessary to help improve identification of different disease subtypes underlying dementia.
Keywords: AD; DLB; Dementia; Mixed pathology; Neuropathology.
Conflict of interest statement
Ethics approval and consent to participate
The tissue and associated data used in this study were from the Newcastle Brain Tissue Resource (NBTR) and used in accordance with ethical approvals for NBTR.
Consent for publication
All authors approved the final manuscript and consent to its publication.
Competing interests
AT has received support from GE Healthcare for investigator-led research. JPT has received honoraria from GE Healthcare for educational presentations. The remaining authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.Acta Neuropathol Commun. 2024 May 7;12(1):73. doi: 10.1186/s40478-024-01786-z. Acta Neuropathol Commun. 2024. PMID: 38715119 Free PMC article.
-
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.Acta Neuropathol. 2015 May;129(5):729-48. doi: 10.1007/s00401-015-1406-3. Epub 2015 Mar 11. Acta Neuropathol. 2015. PMID: 25758940
-
Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.PLoS One. 2017 Feb 6;12(2):e0171524. doi: 10.1371/journal.pone.0171524. eCollection 2017. PLoS One. 2017. PMID: 28166276 Free PMC article.
-
Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review.J Neurol Sci. 2020 Aug 15;415:116886. doi: 10.1016/j.jns.2020.116886. Epub 2020 May 11. J Neurol Sci. 2020. PMID: 32428759
-
How to diagnose dementia with Lewy bodies: state of the art.Mov Disord. 2005 Aug;20 Suppl 12:S11-20. doi: 10.1002/mds.20535. Mov Disord. 2005. PMID: 16092075 Review.
Cited by
-
α-synuclein in the pathophysiology of Alzheimer's disease.Mol Neurodegener. 2019 Jun 11;14(1):23. doi: 10.1186/s13024-019-0320-x. Mol Neurodegener. 2019. PMID: 31186026 Free PMC article. Review.
-
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.J Neural Transm (Vienna). 2019 Aug;126(8):933-995. doi: 10.1007/s00702-019-02028-6. Epub 2019 Jun 18. J Neural Transm (Vienna). 2019. PMID: 31214855 Review.
-
α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies.Front Neurosci. 2025 Mar 27;19:1570553. doi: 10.3389/fnins.2025.1570553. eCollection 2025. Front Neurosci. 2025. PMID: 40212715 Free PMC article. Review.
-
Clinico-pathological comparison of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology.Alzheimers Dement (Amst). 2021 May 18;13(1):e12189. doi: 10.1002/dad2.12189. eCollection 2021. Alzheimers Dement (Amst). 2021. PMID: 34027019 Free PMC article.
-
Association between visual hallucinations and cognitive performance in Lewy body dementia and Alzheimer's disease: A cross-sectional study.J Alzheimers Dis Rep. 2025 May 4;9:25424823251339132. doi: 10.1177/25424823251339132. eCollection 2025 Jan-Dec. J Alzheimers Dis Rep. 2025. PMID: 40330106 Free PMC article.
References
-
- Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree—a new disease? Clin Neuropathol. 1984;3:185–192. - PubMed
-
- McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88–100. doi: 10.1212/WNL.0000000000004058. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous